Mizuho Maintains Outperform on Surgery Partners, Lowers Price Target to $19

Benzinga · 2d ago
Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers the price target from $22 to $19.